Published by
Articles
Cases
Webinars
News
Issues
Digital Portals
AR Connect
Outreach
About Us
Resources
MOST RECENT
New Radiolabeled Antibody Shows Promise for Imaging and Treating Solid Tumors
AI Streamlines Radiopharmaceutical Dosimetry in Prostate Cancer Care
RadNet to Acquire iCAD for $103 Million to Advance AI-Driven Breast Cancer Detection
September 2022 Supplement
Vol 51 • Issue 5
Supplement
The Use of Contrast-enhanced MRI in At-risk Patient Populations
By
Lawrence N. Tanenbaum, MD, FACR
;
Donna Roberts, MD
September 1, 2022
5 not found